Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Transfusion

Retrieve available abstracts of 170 articles:
HTML format

Single Articles

    July 2021
  1. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    PubMed     Abstract available

  2. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.

    June 2021
  3. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    PubMed     Abstract available

  4. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.

  5. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.

    May 2021
  6. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    PubMed     Abstract available

  7. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    PubMed     Abstract available

    April 2021
  8. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    PubMed     Abstract available

  9. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    PubMed     Abstract available

    March 2021
  10. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    PubMed     Abstract available

  11. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    PubMed     Abstract available

    February 2021
  12. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available

  13. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.

  14. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    PubMed     Abstract available

  15. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    PubMed     Abstract available

  16. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    PubMed     Abstract available

    January 2021
  17. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    PubMed     Abstract available

  18. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    PubMed     Abstract available

  19. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.

    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.

  21. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    PubMed     Abstract available

  22. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    PubMed     Abstract available

  23. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.

    December 2020
  24. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    PubMed     Abstract available

  25. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    PubMed     Abstract available

    October 2020
  26. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.

  27. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    PubMed     Abstract available

  28. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available

  29. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    PubMed     Abstract available

    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.

    September 2020
  31. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    PubMed     Abstract available

  32. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    PubMed     Abstract available

    August 2020
  33. ERSHLER WB, Holbrook ME
    Sickle Cell Anemia and COVID-19: Use of Voxelotor to Avoid Transfusion.
    Transfusion. 2020 Aug 19. doi: 10.1111/trf.16068.

  34. BLOCH EM, Branch HA, Sakac D, Leger RM, et al
    Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia.
    Transfusion. 2020 Aug 4. doi: 10.1111/trf.15911.
    PubMed     Abstract available

    July 2020
  35. BIBOULET P, Motais C, Pencole M, Karam O, et al
    Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study.
    Transfusion. 2020 Jul 18. doi: 10.1111/trf.15900.
    PubMed     Abstract available

  36. GUINN NR, Cooter ML, Maisonave Y, Grimsley A, et al
    How do I develop a process to effectively treat parturients with iron deficiency anemia?
    Transfusion. 2020 Jul 13. doi: 10.1111/trf.15930.
    PubMed     Abstract available

    IVIg and hemolytic anemia risk: dump the anti-A/B already!
    Transfusion. 2020;60:1337-1339.

    June 2020
  38. JERICO C, Beverina I, Quintana-Diaz M, Salvadori U, et al
    Efficacy and safety of high-dose intravenous iron as the first-choice therapy in outpatients with severe iron deficiency anemia.
    Transfusion. 2020 Jun 29. doi: 10.1111/trf.15870.
    PubMed     Abstract available

  39. WALLENHORST C, Patel A, Shebl A, Hubsch A, et al
    Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
    Transfusion. 2020 Jun 2. doi: 10.1111/trf.15859.
    PubMed     Abstract available

    May 2020
  40. ZUMBERG M, Gorlin J, Griffiths EA, Schwartz G, et al
    A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
    Transfusion. 2020 May 1. doi: 10.1111/trf.15778.
    PubMed     Abstract available

    April 2020
  41. MAST AE, Langer JC, Guo Y, Bialkowski W, et al
    Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors.
    Transfusion. 2020;60:747-758.
    PubMed     Abstract available

  42. SPENCER BR, Haynes JM, Notari EP 4th, Stramer SL, et al
    Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors.
    Transfusion. 2020;60:759-768.
    PubMed     Abstract available

  43. JAIME-PEREZ JC, Garcia-Salas G, Ancer-Rodriguez J, Gomez-Almaguer D, et al
    Audit of red blood cell transfusion in patients with acute leukemia at a tertiary care university hospital.
    Transfusion. 2020;60:724-730.
    PubMed     Abstract available

    March 2020
  44. BLOCH EM, Hull J, Green-Thompson R, Ingram C, et al
    Antenatal blood transfusion in South Africa: indications and practice in a high-HIV-prevalence setting.
    Transfusion. 2020;60:479-487.
    PubMed     Abstract available

  45. LIN DM, Becker J, Wu Y, Cooling L, et al
    How do I perform whole blood exchange?
    Transfusion. 2020;60:449-453.

    February 2020
  46. HINDAWI S, Badawi M, Elfayoumi R, Elgemmezi T, et al
    The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
    Transfusion. 2020;60 Suppl 1:S15-S21.
    PubMed     Abstract available

  47. ELSHINAWY M, Kamal M, Nazir H, Khater D, et al
    Sepsis-related anemia in a pediatric intensive care unit: transfusion-associated outcomes.
    Transfusion. 2020;60 Suppl 1:S4-S9.
    PubMed     Abstract available

  48. BLATYTA PF, Kelly S, Sabino E, Preiss L, et al
    Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.
    Transfusion. 2020;60:343-350.
    PubMed     Abstract available

    January 2020
  49. GOLDSTEIN GP, Rao A, Ling AY, Ding VY, et al
    Influence of enteral feeding and anemia on tissue oxygen extraction after red blood cell transfusion in preterm infants.
    Transfusion. 2020 Jan 26. doi: 10.1111/trf.15680.
    PubMed     Abstract available

  50. GUDLAUGSSON B, Hjartardottir H, Svansdottir G, Gudmundsdottir G, et al
    Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Transfusion. 2020;60:175-183.
    PubMed     Abstract available

  51. VAN BUREN NL, Gorlin JB, Corby SM, Cassidy S, et al
    How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Transfusion. 2020;60:16-25.
    PubMed     Abstract available

  52. LEE LE, Beeler BW, Graham BC, Cap AP, et al
    Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
    Transfusion. 2020;60:30-35.
    PubMed     Abstract available

    December 2019
  53. JACKSON CHORNENKI NL, James TE, Barty R, Liu Y, et al
    Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study.
    Transfusion. 2019 Dec 28. doi: 10.1111/trf.15649.
    PubMed     Abstract available

  54. COOLING L, Hugan S
    Daratumumab in combination with standard treatment for autoimmune hemolytic anemia in a pediatric patient.
    Transfusion. 2019;59:3801-3802.

    November 2019
  55. ROEHMEL J, Specht P, Staab D, Schwarz C, et al
    Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
    Transfusion. 2019 Nov 14. doi: 10.1111/trf.15591.
    PubMed     Abstract available

    Effect of anemia on muscle oxygen saturation during submaximal exercise.
    Transfusion. 2019 Nov 12. doi: 10.1111/trf.15588.
    PubMed     Abstract available

    October 2019
  57. CRISPIN P, Sliwinski K, Wilson C, Lennard S, et al
    Cold reacting anti-M causing delayed hemolytic disease of the newborn.
    Transfusion. 2019 Oct 31. doi: 10.1111/trf.15578.
    PubMed     Abstract available

  58. WEBB J
    The use of rejuvenated red blood cells for transfusion in patients with sickle cell anemia.
    Transfusion. 2019;59:3042-3045.

    September 2019
  59. BAHR TM, DuPont TL, Christensen TR, Rees T, et al
    Evaluating emergency-release blood transfusion of newborn infants at the Intermountain Healthcare hospitals.
    Transfusion. 2019 Sep 3. doi: 10.1111/trf.15495.
    PubMed     Abstract available

    June 2019
  60. KAMYSZEK RW, Raval JS, Srinivasan AJ, Ansari AK, et al
    Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange.
    Transfusion. 2019 Jun 3. doi: 10.1111/trf.15386.
    PubMed     Abstract available

    May 2019
  61. MILLER J, Cai W, Andrews J, Narla A, et al
    A case series of pediatric patients with direct antiglobulin test negative autoimmune hemolytic anemia.
    Transfusion. 2019 May 21. doi: 10.1111/trf.15350.
    PubMed     Abstract available

  62. VISAGIE M, Pearson KR, Purvis TE, Gehrie EA, et al
    Greater anemia tolerance among hospitalized females compared to males.
    Transfusion. 2019 May 7. doi: 10.1111/trf.15338.
    PubMed     Abstract available

    March 2019
  63. ARTHUR CM, Nalbant D, Feldman HA, Saeedi BJ, et al
    Anemia induces gut inflammation and injury in an animal model of preterm infants.
    Transfusion. 2019 Mar 21. doi: 10.1111/trf.15254.
    PubMed     Abstract available

  64. BURGOS PRATX L, Santoro D, Coca Mogro B, Valiente VL, et al
    Etoricoxib-induced immune hemolytic anemia: first case presenting acute kidney failure.
    Transfusion. 2019 Mar 13. doi: 10.1111/trf.15226.
    PubMed     Abstract available

  65. SHEHATA N, Mazer CD
    Red cell transfusion in cardiac surgery: what is the right balance?
    Transfusion. 2019;59:903-904.
    PubMed     Abstract available

    February 2019
  66. HEQUET O, Poutrel S, Connes P, Revesz D, et al
    Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.
    Transfusion. 2019 Feb 12. doi: 10.1111/trf.15188.
    PubMed     Abstract available

  67. DESIMONE RA, Ong SJ, Crowley KM, Vasovic LV, et al
    Hereditary elliptocytosis of donor red blood cell unit detected during Coombs crossmatch.
    Transfusion. 2019;59:446-447.

  68. MURPHY C, Parakh R, Metcalf R, Pagano MB, et al
    Transfusion-associated chest pain.
    Transfusion. 2019;59:463-469.
    PubMed     Abstract available

  69. DEAN CL, Maier CL, Roback JD, Stowell SR, et al
    Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
    Transfusion. 2019;59:448-453.
    PubMed     Abstract available

    January 2019
  70. QUINTANILLA-BORDAS C, Castro-Izaguirre E, Carcelen-Gadea M, Marin M, et al
    The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.
    Transfusion. 2019 Jan 31. doi: 10.1111/trf.15151.
    PubMed     Abstract available

  71. ROMPHRUK AV, Simtong P, Butryojantho C, Pimphumee R, et al
    The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.
    Transfusion. 2019;59:177-184.
    PubMed     Abstract available

  72. PAVENSKI K, Ward SE, Hare GMT, Freedman J, et al
    A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.
    Transfusion. 2019;59:207-216.
    PubMed     Abstract available

    December 2018
  73. LI S, Mo C, Huang L, Shi X, et al
    Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature.
    Transfusion. 2018 Dec 6. doi: 10.1111/trf.15054.
    PubMed     Abstract available

  74. ANLIKER M, Schmidt CQ, Harder MJ, Ganchev G, et al
    Complement activation by human red blood cell antibodies: hemolytic potential of antibodies and efficacy of complement inhibitors assessed by a sensitive flow cytometric assay.
    Transfusion. 2018;58:2992-3002.
    PubMed     Abstract available

  75. SIMMONDS MJ, Suriany S, Ponce D, Detterich JA, et al
    Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.
    Transfusion. 2018;58:2788-2796.
    PubMed     Abstract available

  76. CULP-HILL R, Srinivasan AJ, Gehrke S, Kamyszek R, et al
    Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism.
    Transfusion. 2018;58:2797-2806.
    PubMed     Abstract available

  77. LAL A, Wong TE, Andrews J, Balasa VV, et al
    Transfusion practices and complications in thalassemia.
    Transfusion. 2018;58:2826-2835.
    PubMed     Abstract available

    November 2018
  78. FONTANALS M, O'Leary JD, Zaarour C, Skelton T, et al
    Preoperative anemia increases the risk of red blood cell transfusion and prolonged hospital length of stay in children undergoing spine arthrodesis surgery.
    Transfusion. 2018 Nov 30. doi: 10.1111/trf.15055.
    PubMed     Abstract available

  79. RUSSELL L, Holst LB, Lange T, Liang X, et al
    Effects of anemia and blood transfusion on clot formation and platelet function in patients with septic shock: a substudy of the randomized TRISS trial.
    Transfusion. 2018 Nov 5. doi: 10.1111/trf.14904.
    PubMed     Abstract available

  80. ALLEN ES, Nelson RC, Flegel WA
    How we evaluate red blood cell compatibility and transfusion support for patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation.
    Transfusion. 2018;58:2483-2489.
    PubMed     Abstract available

  81. LEMAY AS, Tong TN, Branch DR, Huang M, et al
    The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.
    Transfusion. 2018;58:2506-2512.
    PubMed     Abstract available

    October 2018
  82. FURUI Y, Yamagishi N, Morioka I, Taira R, et al
    Sequence analyses of variable cytomegalovirus genes for distinction between breast milk- and transfusion-transmitted infections in very-low-birth-weight infants.
    Transfusion. 2018 Oct 19. doi: 10.1111/trf.14920.
    PubMed     Abstract available

  83. GIJTENBEEK M, Lopriore E, Steggerda SJ, Te Pas AB, et al
    Persistent pulmonary hypertension of the newborn after fetomaternal hemorrhage.
    Transfusion. 2018 Oct 13. doi: 10.1111/trf.14932.
    PubMed     Abstract available

  84. MENCHETTI I, Lin Y, Cserti-Gazdewich C, Goldstein J, et al
    Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis.
    Transfusion. 2018 Oct 6. doi: 10.1111/trf.14888.
    PubMed     Abstract available

  85. KRISHNASIVAM D, Trentino KM, Burrows S, Farmer SL, et al
    Anemia in hospitalized patients: an overlooked risk in medical care.
    Transfusion. 2018 Oct 1. doi: 10.1111/trf.14877.
    PubMed     Abstract available

  86. WILSON MJ, Koopman-van Gemert AWMM, Harlaar JJ, Jeekel J, et al
    Patient blood management in colorectal cancer patients: a survey among Dutch gastroenterologists, surgeons, and anesthesiologists.
    Transfusion. 2018;58:2345-2351.
    PubMed     Abstract available

  87. WARKENTIN TE, Morin PA, Heddle NM
    Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA.
    Transfusion. 2018;58:2320-2325.
    PubMed     Abstract available

    September 2018
  88. NOLAN BE, Wang Y, Pary PP, Luban NLC, et al
    High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14879.
    PubMed     Abstract available

  89. HESS J, Su L, Nizzi F, Beebe K, et al
    Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
    Transfusion. 2018 Sep 4. doi: 10.1111/trf.14907.
    PubMed     Abstract available

  90. GOCKE CB, Shanbhag S
    Neutrophil-red blood cell rosetting in a patient with autoimmune hemolytic anemia.
    Transfusion. 2018;58:2102-2103.

  91. ANAND A, Mace KE, Townsend RL, Madison-Antenucci S, et al
    Investigation of a case of suspected transfusion-transmitted malaria.
    Transfusion. 2018;58:2115-2121.
    PubMed     Abstract available

  92. MAURIN C, Vassal O, Darien M, Raba M, et al
    Immune hemolysis secondary to injection of contrast medium.
    Transfusion. 2018;58:2113-2114.
    PubMed     Abstract available

  93. BLOCH EM, Ingram C, Hull J, Fawcus S, et al
    Risk factors for peripartum blood transfusion in South Africa: a case-control study.
    Transfusion. 2018;58:2149-2156.
    PubMed     Abstract available

  94. VIANELLO A, Vencato E, Cantini M, Zanconato G, et al
    Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis.
    Transfusion. 2018;58:2192-2201.
    PubMed     Abstract available

    August 2018
  95. NIXON CP, Sweeney JD
    Severe iron deficiency anemia: red blood cell transfusion or intravenous iron?
    Transfusion. 2018;58:1824-1826.

  96. BILLER E, Zhao Y, Berg M, Boggio L, et al
    Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB.
    Transfusion. 2018;58:1965-1972.
    PubMed     Abstract available

    July 2018
  97. WIN N, Needs M, Thornton N, Webster R, et al
    Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
    Transfusion. 2018;58:1626-1630.
    PubMed     Abstract available

  98. CAMPBELL-LEE SA, Gvozdjan K, Choi KM, Chen YF, et al
    Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
    Transfusion. 2018;58:1588-1596.
    PubMed     Abstract available

    June 2018
  99. FLOCH A, Gien D, Tournamille C, Chami B, et al
    High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.
    Transfusion. 2018;58:1527-1535.
    PubMed     Abstract available

  100. COMPERNOLLE V, Chou ST, Tanael S, Savage W, et al
    Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline.
    Transfusion. 2018;58:1555-1566.
    PubMed     Abstract available

  101. DEDEKEN L, Le PQ, Rozen L, El Kenz H, et al
    Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload.
    Transfusion. 2018;58:1356-1362.
    PubMed     Abstract available

  102. MAIER CL, Gross PJ, Dean CL, Chonat S, et al
    Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure.
    Transfusion. 2018;58:1550-1554.
    PubMed     Abstract available

    May 2018
  103. GUINN NR, Cooter ML, Villalpando C, Weiskopf RB, et al
    Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion.
    Transfusion. 2018 May 24. doi: 10.1111/trf.14768.
    PubMed     Abstract available

  104. AHMAD I, Majeed Memon A, Moiz B
    Mixed IgM cold and IgG warm autoimmune hemolytic anemia complicated by acral gangrene.
    Transfusion. 2018;58:1093-1094.

    April 2018
  105. YEE MEM, Josephson CD, Winkler AM, Webb J, et al
    Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14610.
    PubMed     Abstract available

  106. KHADADAH F, Callum J, Shelton D, Lin Y, et al
    Improving quality of care for patients with iron deficiency anemia presenting to the emergency department.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14626.
    PubMed     Abstract available

  107. MINAKAWA K, Ohto H, Yasuda H, Saito S, et al
    Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14634.
    PubMed     Abstract available

  108. STEPHAN C, Phulpin A, Steschenko D, Lesesve JF, et al
    Oxidative stress-related infantile pyknocytosis with Heinz bodies.
    Transfusion. 2018;58:840-841.

  109. SCHREIBER GB, Brinser R, Rosa-Bray M, Yu ZF, et al
    Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study.
    Transfusion. 2018;58:951-959.
    PubMed     Abstract available

  110. VAN BUREN NL, Gorlin JB, Reed RC, Gottschall JL, et al
    Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC disease.
    Transfusion. 2018;58:879-883.
    PubMed     Abstract available

  111. GYBEL-BRASK M, Seeberg J, Thomsen LL, Johansson PI, et al
    Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
    Transfusion. 2018;58:974-981.
    PubMed     Abstract available

  112. AL-RIYAMI AZ, Al-Muqbali A, Al-Sudiri S, Murthi Panchatcharam S, et al
    Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
    Transfusion. 2018;58:871-878.
    PubMed     Abstract available

    March 2018
  113. DE LAS NIEVES LOPEZ MA, Matas Cobos AM, Sarria Gonzalez F, Dominguez Lomena MJ, et al
    Red blood cell transfusion after a global strategy for early detection and treatment of iron deficiency anemia: three-year results of a prospective observational study.
    Transfusion. 2018 Mar 26. doi: 10.1111/trf.14582.
    PubMed     Abstract available

  114. SCHOTTEN N, Zalpuri S, Pasker-de Jong PCM, Swinkels DW, et al
    Utility of zinc protoporphyrin in management of whole blood donors.
    Transfusion. 2018;58:692-700.
    PubMed     Abstract available

  115. BENNETT S, Ayoub A, Tran A, English S, et al
    Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists.
    Transfusion. 2018;58:781-787.
    PubMed     Abstract available

  116. IGARASHI T, Fujita H, Asaka H, Takada Y, et al
    Patient rescue and blood utilization in the Ogasawara blood rotation system.
    Transfusion. 2018;58:788-794.
    PubMed     Abstract available

  117. MWESIGWA S, Moulds JM, Chen A, Flanagan J, et al
    Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.
    Transfusion. 2018;58:726-735.
    PubMed     Abstract available

    February 2018
  118. TOLY-NDOUR C, Mourtada H, Huguet-Jacquot S, Maisonneuve E, et al
    Clinical input of anti-D quantitation by continuous-flow analysis on autoanalyzer in the management of high-titer anti-D maternal alloimmunization.
    Transfusion. 2018;58:294-305.
    PubMed     Abstract available

  119. SEIELSTAD M, Page GP, Gaddis N, Lanteri M, et al
    Genomewide association study of HLA alloimmunization in previously pregnant blood donors.
    Transfusion. 2018;58:402-412.
    PubMed     Abstract available

    January 2018
  120. APATA IW, Drammeh B, De AK, Bjork A, et al
    Diagnoses and ordering practices driving blood demand for treatment of anemia in Tanzania.
    Transfusion. 2018 Jan 19. doi: 10.1111/trf.14461.
    PubMed     Abstract available

  121. DAS S, Kumar V, Jafa E, Basavarajegowda A, et al
    Complete disappearance of ABO antigen-a cause of ABO discrepancy.
    Transfusion. 2018;58:5-6.

  122. CHAN KLL, Mak WMV, Tam YH, Lee KKH, et al
    Factors affecting patient-reported outcomes after red blood cell transfusion in medical patients.
    Transfusion. 2018;58:158-167.
    PubMed     Abstract available

  123. DAVIS JM, El-Haj N, Shah NN, Schwartz G, et al
    Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series.
    Transfusion. 2018;58:132-137.
    PubMed     Abstract available

  124. KELLER J, Vege S, Horn T, Keller MA, et al
    Novel mutations in KLF1 encoding the In(Lu) phenotype reflect a diversity of clinical presentations.
    Transfusion. 2018;58:196-199.
    PubMed     Abstract available

  125. MATHUR G, Ten Eyck P, Knudson CM
    Predicting changes in hemoglobin S after simple transfusion using complete blood counts.
    Transfusion. 2018;58:138-144.
    PubMed     Abstract available

    December 2017
  126. WILSON MJ, Dekker JW, Bruns E, Borstlap W, et al
    Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study.
    Transfusion. 2017 Dec 17. doi: 10.1111/trf.14456.
    PubMed     Abstract available

  127. PETTY K, Waters JH, Sakamoto SB, Yazer MH, et al
    Antenatal anemia increases the risk of receiving postpartum red blood cell transfusions although the overall risk of transfusion is low.
    Transfusion. 2017 Dec 1. doi: 10.1111/trf.14434.
    PubMed     Abstract available

    November 2017
  128. PUJOL-NICOLAS A, Morrison R, Casson C, Khan S, et al
    Preoperative screening and intervention for mild anemia with low iron stores in elective hip and knee arthroplasty.
    Transfusion. 2017 Nov 6. doi: 10.1111/trf.14372.
    PubMed     Abstract available

    October 2017
  129. NEDELCU E, Desai M, Green J, Bensing KM, et al
    Acute autoimmune hemolytic anemia due to anti-Ena autoantibody successfully treated with rituximab.
    Transfusion. 2017 Oct 11. doi: 10.1111/trf.14363.
    PubMed     Abstract available

  130. GNIADEK TJ, Arndt PA, Leger RM, Zydowicz D, et al
    Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.
    Transfusion. 2017 Oct 8. doi: 10.1111/trf.14362.
    PubMed     Abstract available

  131. AMREIN K, Macher S, Schrock M, Schlenke P, et al
    Iron deficiency in blood donors: perceptions and management among general practitioners and internists.
    Transfusion. 2017;57:2548-2549.

  132. YOUSSEF LA, Spitalnik SL
    Iron: a double-edged sword.
    Transfusion. 2017;57:2293-2297.

    September 2017
  133. LINNIK YA, Tsui EW, Martin IW, Szczepiorkowski ZM, et al
    The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
    Transfusion. 2017 Sep 14. doi: 10.1111/trf.14315.
    PubMed     Abstract available

  134. PIETY NZ, Reinhart WH, Stutz J, Shevkoplyas SS, et al
    Optimal hematocrit in an artificial microvascular network.
    Transfusion. 2017;57:2257-2266.
    PubMed     Abstract available

  135. GEHRIE EA, Ness PM, Bloch EM, Kacker S, et al
    Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.
    Transfusion. 2017;57:2267-2276.
    PubMed     Abstract available

  136. BALLAS SK
    From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell disease.
    Transfusion. 2017;57:2277-2280.
    PubMed     Abstract available

    August 2017
  137. YEE MEM, Josephson CD, Winkler AM, Webb J, et al
    Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Transfusion. 2017 Aug 24. doi: 10.1111/trf.14282.
    PubMed     Abstract available

  138. LASO-MORALES M, Jerico C, Gomez-Ramirez S, Castellvi J, et al
    Preoperative management of colorectal cancer-induced iron deficiency anemia in clinical practice: data from a large observational cohort.
    Transfusion. 2017 Aug 21. doi: 10.1111/trf.14278.
    PubMed     Abstract available

  139. YADAV S, Shetty S, Kulkarni B
    A novel homozygous frameshift mutation in Exon 7 of the ADAMTS13 gene in a patient with congenital thrombotic thrombocytopenic purpura from India: a case report.
    Transfusion. 2017 Aug 21. doi: 10.1111/trf.14279.
    PubMed     Abstract available

    July 2017
  140. BAILEN R, Kwon M, Perez-Corral AM, Pascual C, et al
    Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation.
    Transfusion. 2017 Jul 13. doi: 10.1111/trf.14232.
    PubMed     Abstract available

  141. KISS JE, Birch RJ, Steele WR, Wright DJ, et al
    Quantification of body iron and iron absorption in the REDS-II Donor Iron Status Evaluation (RISE) study.
    Transfusion. 2017;57:1656-1664.
    PubMed     Abstract available

    June 2017
  142. SUFFREDINI DA, Xu W, Sun J, Barea-Mendoza J, et al
    Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.
    Transfusion. 2017 Jun 27. doi: 10.1111/trf.14214.
    PubMed     Abstract available

  143. ANANI W, Wucinski J, Baumann Kreuziger L, Gottschall J, et al
    Therapeutic plasma exchange in refractory warm autoimmune hemolytic anemia.
    Transfusion. 2017;57:1336.

  144. WILEN CB, Booth GS, Grossman BJ, Lane WJ, et al
    Using direct antiglobulin test results to reduce unnecessary cold agglutinin testing.
    Transfusion. 2017;57:1480-1484.
    PubMed     Abstract available

    Kids, colds, and complement: paroxysmal cold hemoglobinuria.
    Transfusion. 2017;57:1332-1335.

    May 2017
  146. HULBERT ML, Panepinto JA, Scott JP, Liem RI, et al
    Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Transfusion. 2017 May 12. doi: 10.1111/trf.14155.
    PubMed     Abstract available

  147. GNIADEK TJ, McGonigle AM, Shirey RS, Brunker PA, et al
    A rare, potentially life-threatening presentation of passenger lymphocyte syndrome.
    Transfusion. 2017;57:1262-1266.
    PubMed     Abstract available

  148. GRENINGER AL, Hess JR
    Clostridium perfringens sepsis masquerading as a hemolytic transfusion reaction.
    Transfusion. 2017;57:1112.

    April 2017
  149. BISWAS A, Firdaus R, Gupta D, Ghosh M, et al
    Interferon lambda3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Transfusion. 2017 Apr 16. doi: 10.1111/trf.14070.
    PubMed     Abstract available

  150. GOEL R, Snow J, Pri-Paz SM, Cushing M, et al
    Intrauterine transfusions for severe fetal anemia and hydrops due to de novo epsilongammadeltabeta-thalassemia.
    Transfusion. 2017;57:876.

  151. GHESQUIERE L, Houfflin-Debarge V, Behal H, Coulon C, et al
    Should optimal timing between two intrauterine transfusions be based on estimated daily decrease of hemoglobin or on measurement of fetal middle cerebral artery peak systolic velocity?
    Transfusion. 2017;57:899-904.
    PubMed     Abstract available

    March 2017
  152. PRINCE SD, Winestone LE, Nance SJ, Friedman DF, et al
    Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report.
    Transfusion. 2017 Mar 31. doi: 10.1111/trf.14032.
    PubMed     Abstract available

  153. RAUCH S, Ritgen J, Wisskirchen M, Bauerfeind U, et al
    A case of anti-Rd causing fetal anemia.
    Transfusion. 2017 Mar 7. doi: 10.1111/trf.14078.
    PubMed     Abstract available

  154. DELANEY M, Wikman A, van de Watering L, Schonewille H, et al
    Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study.
    Transfusion. 2017;57:525-532.
    PubMed     Abstract available

  155. ODUOR H, Minniti CP, Brofferio A, Gharib AM, et al
    Severe cardiac iron toxicity in two adults with sickle cell disease.
    Transfusion. 2017;57:700-704.
    PubMed     Abstract available

  156. MAST AE
    Putting donor health first in strategies to mitigate donor iron deficiency.
    Transfusion. 2017;57:495-498.

  157. LOPEZ GH, Wilson B, Liew YW, Kupatawintu P, et al
    An alloantibody in a homozygous GYP*Mur individual defines JENU (MNS49), a new high-frequency antigen on glycophorin B.
    Transfusion. 2017;57:716-717.

    February 2017
  158. ZIMAN A, Cohn C, Carey PM, Dunbar NM, et al
    Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice.
    Transfusion. 2017;57:463-477.
    PubMed     Abstract available

  159. SIPPERT EA, Visentainer JE, Alves HV, Rodrigues C, et al
    Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms.
    Transfusion. 2017;57:379-389.
    PubMed     Abstract available

  160. AL-JADA NA
    A Jordanian family with three sisters apparently homozygous for Mk and evidence for clinical significance of antibodies produced by Mk Mk individuals.
    Transfusion. 2017;57:376-378.
    PubMed     Abstract available

    January 2017
  161. PRABHU M, Bateman BT
    Postpartum anemia: missed opportunities for prevention and recognition.
    Transfusion. 2017;57:3-5.

  162. ZELLER MP, Arnold DM, Al Habsi K, Cserti-Gazdewich C, et al
    Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients.
    Transfusion. 2017;57:137-143.
    PubMed     Abstract available

    December 2016
  163. KROMKER M, Lauscher P, Kertscho H, Zacharowski K, et al
    Anemia tolerance during normo-, hypo-, and hypervolemia.
    Transfusion. 2016 Dec 19. doi: 10.1111/trf.13942.
    PubMed     Abstract available

  164. STYRON JF, Klika AK, Szubski CR, Tolich D, et al
    Relative efficacy of tranexamic acid and preoperative anemia treatment for reducing transfusions in total joint arthroplasty.
    Transfusion. 2016 Dec 17. doi: 10.1111/trf.13955.
    PubMed     Abstract available

  165. CONSTANTINOU VC, Bouinta A, Karponi G, Zervou F, et al
    Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with beta-thalassemia major.
    Transfusion. 2016 Dec 17. doi: 10.1111/trf.13951.
    PubMed     Abstract available

    November 2016
  166. WEISKOPF RB, Beliaev AM, Shander A, Guinn NR, et al
    Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers.
    Transfusion. 2016 Nov 18. doi: 10.1111/trf.13923.

    September 2016
  167. BUTWICK AJ, Walsh EM, Kuzniewicz M, Li SX, et al
    Patterns and predictors of severe postpartum anemia after Cesarean section.
    Transfusion. 2016 Sep 13. doi: 10.1111/trf.13815.
    PubMed     Abstract available

  168. LAKKARAJA M, Jin JC, Manotas KC, Vinograd CA, et al
    Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
    Transfusion. 2016 Sep 9. doi: 10.1111/trf.13779.
    PubMed     Abstract available

  169. MUNOZ M, Gomez-Ramirez S, Auerbach M
    Stimulating erythropoiesis before hip fracture repair for reducing blood transfusion: should we change the hemoglobin cutoff level for defining anemia in females?
    Transfusion. 2016;56:2160-3.

    August 2016
  170. GERMAIN M, Delage G, Robillard P, Katz LM, et al
    The association between frequency of blood donation and the occurrence of low birthweight, preterm delivery, and stillbirth: a retrospective cohort study.
    Transfusion. 2016 Aug 11. doi: 10.1111/trf.13762.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.